InnoCare Pharma and Zenas BioPharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multip
InnoCare Pharma Limited and Zenas BioPharma, Inc. today announced a transformational license agreement granting Zenas global develop
October 8, 2025
by InnoCare Pharma
Drug Development: Latest Strategies to Fast-Track Innovation
The conventional drug development pipeline—from target discovery through clinical trials to regulatory approval—traditionally spans more than a decade and costs billions of dollars.
September 28, 2025
by Sadia Ajmal
Introduction of Ubiquicidin (29–41) as an Emerging Infection Imaging Agent
The diagnosis of infectious diseases continues to challenge clinicians, particularly when it comes to distinguishing active infection from sterile inflammation or malignant processes.
September 28, 2025
by Sadia Ajmal
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Over the last couple of years, AI and blockchain have made inroads into the life sciences industry, including the pharmaceutical supply chain network.
September 19, 2025
by Saher Haider
The Rise of Biosimilars: Regulatory Pathways and Market Outlook
Biosimilars are changing the way healthcare systems manage the high cost of advanced medicines.
September 19, 2025
by Nurah Ekhlaque
Basic Concepts and Latest Trends in Radiation Biology: Emerging Insights and Future Directions
This article outlines the basic concepts of radiation biology—including types of radiation, mechanisms of DNA damage, repair pathways, and biological outcomes—followed by a synthesis of the latest trends shaping the field.
September 18, 2025
by Sadia Ajmal
mRNA Beyond Vaccines: Expanding Applications in Pharma
When most of us think of mRNA technology, COVID-19 vaccines instantly come to mind. But mRNA is not just a vaccine superstar, it’s an emerging powerhouse in pharmaceutical innovation.
September 12, 2025
by Nurah Ekhlaque
Orphan Drugs as Strategic Assets: Lifecycle Patterns, Sales Resilience, and Market Impact
This analysis refutes the misconception of orphan drugs as niche products. Using 2025 Q1 sales data and lifecycle patterns, it demonstrates their long-term revenue resilience and strategic portfolio value.
September 12, 2025
by N55.6761
How to select a Water Treatment Plant for your pharma applications
Water is the basic raw material in the pharmaceutical industry, and its quality, efficacy, and safety affect the product being manufactured.
September 12, 2025
by Muhammad Asim Niazi
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
The Chinese Pharmacopoeia 2025 has introduced significant revisions to the 9101 Guidelines for Validation of Analytical Methods further promoting the application of statistics in analytical method validation.
September 12, 2025
by Xing Xing
Understanding Pharmaceutical Transfer Panels: Design, Function, and Compliance
In the pharmaceutical industry, utility and distribution systems ensure essential services, such as water, compressed air, and steam, in the entire manufacturing plant.
September 12, 2025
by Muhammad Asim Niazi
Stainless Steel for Pharmaceutical Applications: Grades, Properties, and Best Practices
Selecting appropriate material of construction is critical for product quality, safety, and regulatory compliance, in the manufacturing industry.
September 12, 2025
by Muhammad Asim Niazi